Concepedia

Publication | Open Access

Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients

DOIFull Paper Access

180

Citations

21

References

2015

Year

Edward Shelton, Jessica R. Allegretti, Betsy W. Stevens, Matthew Lucci, Hamed Khalili, Deanna D. Nguyen, Jenny Sauk, Cosmas Giallourakis, John J. Garber, Matthew J. Hamilton,
Inflammatory Bowel Diseases

Abstract

VDZ is safe and well tolerated in refractory inflammatory bowel disease patients in a clinical practice with efficacy in UC and CD with responses similar to what was seen in clinical trials.

References

YearCitations

Page 1